CVS

CVS HEALTH
D

CVS

Arincen56/100B

CVS HEALTH company profile

CEO
J. David Joyner
Employees
259,500
Headquarters
One CVS Drive, Woonsocket, RI 02895, US
Sector
Healthcare
Industry
Medical - Healthcare Plans
IPO date
21 Feb 1973
Stock exchange
NYSE
ISIN
US1266501006

Website:cvshealth.com

About the company

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Employees

CVS HEALTH had about 300,000 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 0.0% more than a year before.

Employees Change on the year
Fiscal yearEmployeesChange on the yearRevenue per employeeNet income per employee
FY2025300,0000.00%1.34M USD5.89K USD
FY2024300,0000.00%1.24M USD15.38K USD
FY2023300,0000.00%1.19M USD27.81K USD
FY2022300,0000.00%1.07M USD14.37K USD
FY2021300,0000.00%973.70K USD26.67K USD
FY2020300,000+3.45%895.69K USD23.93K USD
FY2019290,000-1.69%885.43K USD22.88K USD
FY2018295,000+19.92%659.59K USD-2.01K USD
FY2017246,000-1.60%751.16K USD26.92K USD
FY2016250,000+2.88%710.18K USD21.27K USD
FY2015243,000+11.57%630.82K USD21.55K USD
FY2014217,800+4.71%639.89K USD21.32K USD
FY2013208,000+2.46%609.43K USD22.08K USD
FY2012203,000+0.50%606.50K USD19.03K USD
FY2011202,000+0.50%530.10K USD17.14K USD
FY2010201,000-4.74%476.51K USD17.05K USD
FY2009211,000-1.86%465.47K USD17.52K USD
FY2008215,000+7.50%406.85K USD14.94K USD
FY2007200,000+13.64%——
FY2006176,000+18.92%——
FY2005148,000+1.72%250.05K USD8.28K USD
FY2005145,500+32.27%——
FY2004110,000+4.76%——
FY2002105,000-1.87%——
FY2001107,000+8.08%——
FY200099,000-1.00%——
FY2000100,000+3.09%——
FY199897,000+7.78%157.46K USD3.96K USD
FY199790,000-91.00%152.77K USD986.67 USD
FY19961,000,000+930.93%11.83K USD208.20 USD
FY199597,000-17.09%100.65K USD-5.91K USD
FY1994117,000+5.41%96.46K USD2.63K USD
FY1993111,000—94.01K USD2.99K USD

Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.

Who owns CVS HEALTH

Institutions such as funds, banks and insurers held 90.3% of CVS HEALTH's shares on 30 June 2026, 2,182 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.

Institutions 90.3%Other shareholders 9.7%

Common questions about CVS HEALTH

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.